Lucira Health, Inc. – NASDAQ:LHDX
Lucira Health stock price monthly change
Lucira Health stock price quarterly change
Lucira Health stock price yearly change
Lucira Health key metrics
Market Cap | 18.36M |
Enterprise value | 26.50M |
P/E | -0.14 |
EV/Sales | 0.12 |
EV/EBITDA | -0.19 |
Price/Sales | 0.08 |
Price/Book | 0.29 |
PEG ratio | N/A |
EPS | -3.57 |
Revenue | 212.13M |
EBITDA | -136.27M |
Income | -143.00M |
Revenue Q/Q | 129.63% |
Revenue Y/Y | 558.80% |
Profit margin | -67.54% |
Oper. margin | -66.89% |
Gross margin | -18.39% |
EBIT margin | -66.89% |
EBITDA margin | -64.24% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLucira Health stock price history
Lucira Health stock forecast
Lucira Health financial statements
| Dec 2021 | 61.12M | -7.54M | -12.34% |
|---|---|---|---|
| Mar 2022 | 90.47M | 13.07M | 14.45% |
| Jun 2022 | 26.14M | -21.67M | -82.91% |
| Sep 2022 | 34.39M | -126.86M | -368.89% |
| 2022-08-15 | -0.85763 | -0.54 |
|---|---|---|
| 2022-11-14 | -25.90717 | -3.15 |
| 2023-03-10 | -0.4 | -0.03 |
| Dec 2021 | 240354000 | 51.55M | 21.45% |
|---|---|---|---|
| Mar 2022 | 304362000 | 99.73M | 32.77% |
| Jun 2022 | 289036000 | 103.96M | 35.97% |
| Sep 2022 | 189185000 | 128.29M | 67.82% |
| Dec 2021 | -10.03M | -4.61M | 1.00M |
|---|---|---|---|
| Mar 2022 | -5.30M | -8.13M | 29.20M |
| Jun 2022 | -38.77M | -6.09M | 12K |
| Sep 2022 | -28.24M | -7.17M | 234K |
Lucira Health alternative data
| Aug 2023 | 221 |
|---|---|
| Sep 2023 | 221 |
| Oct 2023 | 221 |
| Nov 2023 | 221 |
| Dec 2023 | 221 |
| Jan 2024 | 221 |
| Feb 2024 | 221 |
| Mar 2024 | 221 |
| Apr 2024 | 221 |
| May 2024 | 221 |
| Jun 2024 | 221 |
| Jul 2024 | 221 |
Lucira Health other data
| Period | Buy | Sel |
|---|---|---|
| Mar 2022 | 30000 | 0 |
| Jun 2022 | 10000 | 1321 |
| Jul 2022 | 0 | 248 |
| Aug 2022 | 0 | 32654 |
| Sep 2022 | 20000 | 17586 |
| Nov 2022 | 0 | 14456 |
| Dec 2022 | 0 | 5846 |
| Feb 2023 | 0 | 5028 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | KASHMOLAH GHAZI officer: Ex VP & Chief Quality .. | Common Stock | 5,028 | $0.27 | $1,358 | ||
Sale | ALLEN ANTHONY JOSEPH officer: Chief Operations Officer | Common Stock | 4,263 | $0.16 | $682 | ||
Sale | NARIDO RICHARD CLAVANO officer: Interim CFO | Common Stock | 1,583 | $0.36 | $570 | ||
Sale | COLLINS KEVIN WALTER officer: Chief Revenue Officer | Common Stock | 9,666 | $0.42 | $4,060 | ||
Sale | KASHMOLAH GHAZI officer: Ex VP & Chief Quality .. | Common Stock | 4,790 | $0.35 | $1,677 | ||
Sale | ALLEN ANTHONY JOSEPH officer: Chief Operations Officer | Common Stock | 17,052 | $1.39 | $23,702 | ||
Sale | GEORGE DAN officer: CFO and Treasurer | Common Stock | 343 | $1.38 | $473 | ||
Purchase | ENGELSON ERIK T. director, officer.. | Common Stock | 20,000 | $1.82 | $36,400 | ||
Sale | MITRA DEBKISHORE director, officer.. | Common Stock | 191 | $1.69 | $324 | ||
Sale | COLLINS KEVIN WALTER officer: Chief Revenue Officer | Common Stock | 8,580 | $1.72 | $14,758 |
| Quarter | Transcript |
|---|---|
| Q3 2022 14 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 16 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 13 May 2022 | Q1 2022 Earnings Call Transcript |
| Q4 2021 10 Mar 2022 | Q4 2021 Earnings Call Transcript |
-
When is Lucira Health's next earnings date?
Unfortunately, Lucira Health's (LHDX) next earnings date is currently unknown.
-
Does Lucira Health pay dividends?
No, Lucira Health does not pay dividends.
-
How much money does Lucira Health make?
Lucira Health has a market capitalization of 18.36M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 34492.94% to 93.06M US dollars. Lucira Health made a loss 64.83M US dollars in net income (profit) last year or -$0.03 on an earnings per share basis.
-
What is Lucira Health's stock symbol?
Lucira Health, Inc. is traded on the NASDAQ under the ticker symbol "LHDX".
-
What is Lucira Health's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Lucira Health?
Shares of Lucira Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Lucira Health's key executives?
Lucira Health's management team includes the following people:
- Mr. Erik T. Engelson Pres, Chief Executive Officer & Director(age: 65, pay: $369,690)
- Dr. Debkishore Mitra Ph.D. Chief Technology Officer & Director(age: 38, pay: $311,350)
-
How many employees does Lucira Health have?
As Jul 2024, Lucira Health employs 221 workers.
-
When Lucira Health went public?
Lucira Health, Inc. is publicly traded company for more then 4 years since IPO on 4 Feb 2021.
-
What is Lucira Health's official website?
The official website for Lucira Health is lucirahealth.com.
-
Where are Lucira Health's headquarters?
Lucira Health is headquartered at 1412 62nd Street, EmeryVille, CA.
-
How can i contact Lucira Health?
Lucira Health's mailing address is 1412 62nd Street, EmeryVille, CA and company can be reached via phone at +51 03508071.
Lucira Health company profile:
Lucira Health, Inc.
lucirahealth.comNASDAQ
221
Medical - Devices
Healthcare
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.
EmeryVille, CA 94608
CIK: 0001652724
ISIN: US54948U1051
CUSIP: 54948U105
